Merck & Co Inc (MRK)
121.45
-0.07
(-0.06%)
USD |
NYSE |
Mar 18, 16:00
121.99
+0.54
(+0.44%)
After-Hours: 20:00
Merck Cash from Investing (TTM): -14.08B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -14.08B |
September 30, 2023 | -15.88B |
June 30, 2023 | -16.51B |
March 31, 2023 | -6.146B |
December 31, 2022 | -4.96B |
September 30, 2022 | -15.26B |
June 30, 2022 | -15.36B |
March 31, 2022 | -16.99B |
December 31, 2021 | -16.56B |
September 30, 2021 | -9.284B |
June 30, 2021 | -10.38B |
March 31, 2021 | -8.553B |
December 31, 2020 | -9.443B |
September 30, 2020 | -5.428B |
June 30, 2020 | -3.082B |
March 31, 2020 | -4.625B |
December 31, 2019 | -2.629B |
September 30, 2019 | 312.00M |
June 30, 2019 | 1.781B |
March 31, 2019 | 4.879B |
December 31, 2018 | 4.314B |
September 30, 2018 | 2.078B |
June 30, 2018 | 1.089B |
March 31, 2018 | -711.00M |
December 31, 2017 | 2.679B |
Date | Value |
---|---|
September 30, 2017 | 174.00M |
June 30, 2017 | -1.387B |
March 31, 2017 | -1.758B |
December 31, 2016 | -3.21B |
September 30, 2016 | -1.264B |
June 30, 2016 | -435.00M |
March 31, 2016 | 3.588B |
December 31, 2015 | -4.758B |
September 30, 2015 | 3.063B |
June 30, 2015 | -598.00M |
March 31, 2015 | -3.172B |
December 31, 2014 | -374.00M |
September 30, 2014 | -6.401B |
June 30, 2014 | -4.716B |
March 31, 2014 | -5.802B |
December 31, 2013 | -3.148B |
September 30, 2013 | -8.723B |
June 30, 2013 | -8.525B |
March 31, 2013 | -7.688B |
December 31, 2012 | -6.805B |
September 30, 2012 | -4.091B |
June 30, 2012 | -2.515B |
March 31, 2012 | -3.265B |
December 31, 2011 | -2.89B |
September 30, 2011 | -2.213B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-16.99B
Minimum
Mar 2022
4.879B
Maximum
Mar 2019
-8.410B
Average
-8.918B
Median
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Gilead Sciences Inc | -2.265B |
Johnson & Johnson | 878.00M |
Harpoon Therapeutics Inc (DELISTED) | 3.283M |
Moderna Inc | 4.206B |